Delphi Genetics: Alma Bio Therapeutics and Delphi Genetics Expand Alliance
On June 26, 2017, Alma Bio Therapeutics and Delphi Genetics announced an expansion of their strategic alliance to develop plasmid DNA drugs. The companies have been collaborating since 2014 on generating a plasmid DNA drug for Alma s preclinical efficacy studies. Under the terms of this alliance
Read full article »
Delphi Genetics is a contract development and manufacturing organization that commercializes cell and gene therapies for the pharmaceutical industry.
Read more